Integrated Diagnostics
portfoliocompanies
company snapshot

Integrated Diagnostics develops large-scale, blood-based molecular diagnostics that leverage advances in proteomics and genomics to detect disease at its earliest stage. It leverages emerging technologies to develop diagnostic products used by physicians and patients to manage complex and serious diseases like cancer, diabetes and Alzheimer's. The company’s products work through blood tests that can monitor tens to hundreds of disease markers simultaneously. Integrated Diagnostics is headquartered in Seattle, Washington.